Store
GS2 · Health

16 fixed-dose combinations banned under Section 26A

2 min readHealth
Battle IAS current affairs title card: 16 fixed-dose combinations banned under Section 26A (GS2 · Health, 20 June 2026)
Battle Brief

The Health Ministry prohibited manufacture, sale and distribution for human use of 16 Fixed Dose Combinations under Section 26A of the Drugs and Cosmetics Act, 1940, with immediate effect from 20 June 2026. An Expert Committee under DTAB reviewed FDCs after Supreme Court directions. The list covers certain dermatological, analgesic/antispasmodic and antibiotic combinations found to lack therapeutic justification.

Fact File

Release
20 Jun 2026, Ministry of Health and Family Welfare
Power used
Section 26A, Drugs and Cosmetics Act, 1940
Count
16 FDCs prohibited with immediate effect
Process
Supreme Court-mandated review; DTAB Expert Committee
Categories
dermatological; analgesic/antispasmodic; antibiotic-based
Gazette
e-Gazette link in the release
In the news

Ban on 16 fixed-dose combinations under Section 26A: what happened?

An FDC packs two or more drugs in one pill. If the mix has no science behind it, patients get extra risk without extra benefit. Section 26A is the Centre’s tool to pull such products off the market.

  • Examples on the list: Acetyl Salicylic acid + Ethoheptazine; several aloe/vitamin skin mixes; Dicyclomine + Paracetamol + Clidinium (with/without Chlordiazepoxide); Gliclazide + Chromium Picolinate; antibiotic combos with Serratiopeptidase or Probenecid.
  • State Drug Controllers told to enforce; manufacturers and distributors to comply.
Back Story

What is Section 26A?

  • It lets the Central Government prohibit manufacture, sale or distribution of a drug in the public interest when it is risky or lacks therapeutic justification.
Why examiners care

Why does ban on 16 fixed-dose combinations under Section 26A matter?

  • Public health: Rational drug use; lower exposure to unjustified combos.
  • AMR angle: Antibiotic FDCs among those pulled.
Exam Radar

What can Prelims ask on ban on 16 fixed-dose combinations under Section 26A?

  • 16 FDCs banned under s.26A, Drugs and Cosmetics Act, 1940 (Jun 2026).
  • Followed SC-directed DTAB Expert Committee review.

How to use this in Mains

GS-II Issues relating to development and management of health

  1. As per PIB (2026-06-20): the Health Ministry prohibited manufacture, sale and distribution of 16 FDCs under Section 26A of the Drugs and Cosmetics Act, 1940.
  2. Banning irrational combinations supports rational drug use and helps fight AMR.
Quotable data point

The Health Ministry prohibited manufacture, sale and distribution of 16 FDCs under Section 26A of the Drugs and Cosmetics Act, 1940.

PIB: Health: FDC ban, 20 Jun 2026

Exam angle

UPSC

Prelims: Section 26A.

Practice MCQs

Original practice questions (not PYQs).

Practice · UPSC

The June 2026 ban on 16 FDCs was issued under

Answer (b) & explanation

PIB (Health), 20 Jun 2026.

Quick questions

Questions students ask about this

How many FDCs were banned?

Sixteen, with immediate effect.

Under which law?

Section 26A of the Drugs and Cosmetics Act, 1940.

Why were they banned?

Expert review found they lacked therapeutic justification relative to risk.

Keep studying

Go deeper

ExplainerOne Health Approach: Why Human, Animal and Environmental Health Are Linked, Zoonotic Diseases, the Global Quadripartite and India’s National One Health Mission (UPSC Notes + PYQs)ExplainerAntimicrobial Resistance (AMR): How Superbugs Arise, the Global and Indian Burden, Causes in Hospitals, Farms and the Environment, and India’s National Action Plan 2.0 (UPSC Notes + PYQs)

Official source: PIB: Health: FDC ban, 20 Jun 2026

facts from cited sources only; faculty review pending